前收市價 | 1.9500 |
開市 | 1.9000 |
買盤 | 1.6000 |
賣出價 | 2.7000 |
拍板 | 25.00 |
到期日 | 2024-06-21 |
今日波幅 | 1.9000 - 2.0500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3.64k |
4D Molecular Therapeutics (FDMT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of -13.24% and 100.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Lyra Therapeutics, Inc. (LYRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.